Stability of ceftazidime in a viscous eye drop formulation

Journal of Clinical Pharmacy and Therapeutics

Volumn 24, Issue 4, 1999, Pages 299-302

  Barnes, A R ^a,c   Nash, S ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; DRUG VEHICLE; EYE DROPS; POLYVINYL ALCOHOL; PYRIDINE; RUBBER;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DEGRADATION; DRUG FORMULATION; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; REGRESSION ANALYSIS;

CEFTAZIDIME; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; LINEAR MODELS; OPHTHALMIC SOLUTIONS; POLYVINYL ALCOHOL; PYRIDINES; TEMPERATURE; TIME FACTORS; VISCOSITY;

EID: 0032773240     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1999.00230.x     Document Type: Article

References (13)

1. 1. Barnes AR. (1997) Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation. Journal of Liquid Chromatography, 18, 3117-3128.
2. 2. Barnes AR, Nash S. (1994) Preservative efficacy in cefuroxime and ceftazidime eye drop formulations. Journal of Clinical Pharmacy and Therapeutics, 19, 327-332.
3. 3. Hill DG, Barnes AR. (1997) Compatibility of phenylmercuric acetate with cefuroxime and ceftazidime eye drops. International Journal of Pharmaceutics, 147, 127-129.
4. 4. Zhou M, Notari RE. (1995) Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions. Journal of Pharmaceutical Sciences, 84, 534-538.
5. 5. Anon. (1989) Guideline for Submitting Documentation for the Stability of Human Drugs and Biologics. Food and Drug Administration, Rockville, Maryland, U.S.A.
6. 6. Ahmed ST, Parkinson R. (1992) The stability of drugs in pre-filled syringes: flucloxacillin, ampicillin, cefuroxime, cefotaxime and ceftazidime. Hospital Pharmacy Practice, April, 285-286, 288-289.
7. 7. Nahata MC, Morosco RS. (1992) Measurement of ceftazidime arginine in aqueous solution by HPLC. Journal of Liquid Chromatography, 13, 1507-1511.
8. 8. Nahata MC, Morosco MC, Fox JL. (1992) Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures. American Journal of Hospital Pharmacy, 49, 2954-2956.
9. 9. Stewart JT, Warren FW, Fox JL, Mullaney J. (1992) Stability of ceftazidime in plastic syringes and glass vials under various storage conditions. American Journal of Hospital Pharmacy, 49, 2765-2768.
10. 10. Stiles ML, Allen LV Jr, Fox JL. (1992) Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs. American Journal of Hospital Pharmacy, 49, 2761-2764.
11. 11. Das Gupta V, Bethea C, de la Torre M. (1988) Chemical stabilities of cefoperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections. Journal of Clinical Pharmacy and Therapeutics, 13, 199-205.
12. 12. Hughes WF Jr. (1948) The tolerance of rabbit cornea for various chemical substances. Appendix I. Bulletin of Johns Hopkins Hospital, 82, 338-339.
13. 13. Fubara JO, Notari RE. (1998) Kinetic oxymoron: concentration-dependent first-order rate constants for hydrolysis of ceftazidime. Journal of Pharmaceutical Sciences, 87, 53-58.